MSU
INSY

Mizuho Securities USA’s Insys Therapeutics, Inc. INSY Stock Holding History

Mizuho Securities USA’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,000
Closed -$116K – 246
2016
Q2 		$116K Hold
9,000
– – 0.02% 174
2016
Q1 		$144K Buy
+9,000
New +$171K 0.03% 104

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mizuho Securities USA's INSY Position: Q3 2016 in Review

Mizuho Securities USA sold out of Insys Therapeutics, Inc. (INSY) in Q3 2016, closing a stake of 9,000 shares — an estimated $116K sold.

Mizuho Securities USA first reported a position in INSY in Q1 2016 and held it in 2 quarters. The position peaked at $144K in Q1 2016. 138 funds tracked by Wall St. Rank hold INSY as of Q3 2016.

  • Mizuho Securities USA reported no remaining Insys Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • Mizuho Securities USA sold 9,000 Insys Therapeutics, Inc. shares in Q3 2016, an estimated $116K.
  • Mizuho Securities USA first reported a position in Insys Therapeutics, Inc. in Q1 2016 and held it in 2 quarters.
  • Mizuho Securities USA's Insys Therapeutics, Inc. position peaked at $144K in Q1 2016.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2016.

Based on Mizuho Securities USA's 13F filing for Q3 2016, filed 21 Oct 2016.